Executive Summary
The Hain Celestial Group posted a challenging QQ3 2025 with a revenue decline and a significant margin deterioration that culminated in a meaningful net loss. Revenue stood at $390.35 million, down 10.95% year-over-year and 5.14% quarter-over-quarter, while gross profit remained $84.65 million for a gross margin of 21.69%. Operating income was negative $121.08 million and EBITDA negative $111.81 million, producing a net loss of $134.59 million and an EPS of -1.49 for the quarter. The combination of elevated selling, general and administrative expenses alongside higher other expenses drove a steep drop in profitability, with the net income margin at roughly -34.5%.
From a cash flow and balance-sheet perspective, operating cash flow was modest at $4.65 million, with free cash flow of -$2.28 million, and cash at period end of $44.43 million. Total debt stood at $774.96 million (net debt $730.53 million), yielding a debt-to-capitalization framework that remains conservative but adds leverage pressure given the ongoing losses. The current ratio was 1.81x, indicating adequate near-term liquidity, while the cash ratio remained thin at 0.15x. Management faces a difficult but potentially actionable path to stabilize margins, improve working capital efficiency, and generate sustainable cash flow.
In the context of the Consumer Defensive landscape, Hain Celestial operates in a niche of organic and natural products with broad international exposure. The QQ3 results underscore the need for disciplined cost containment, pricing discipline, and a strategic mix shift toward higher-margin SKUs and faster-growing channels. The valuation framework appears attractive on several metrics given negative earnings, but execution risk remains high as the company seeks to transition toward profitability.
Key Performance Indicators
QoQ: -5.14% | YoY:-10.95%
QoQ: -9.42% | YoY:-12.43%
QoQ: -31.75% | YoY:-333.96%
QoQ: -29.44% | YoY:-179.26%
QoQ: -29.57% | YoY:-175.93%
Key Insights
Revenue: $390.351 million; YoY decline -10.95%; QoQ decline -5.14%.
Gross Profit: $84.65 million; Gross Margin: 21.69% (0.2169).
Operating Income: -$121.08 million; Operating Margin: -31.02%.
EBITDA: -$111.81 million; EBITDA Margin: -28.64% (approximate, based on EBITDA / revenue).
Net Income: -$134.59 million; Net Margin: -34.48%.
EPS: -$1.49; Weighted Avg Shares: 90.25 million (approximate from data: 90,247,000).
Cash Flow: Net cash from operating activities $4.65 million; Capex $6.92 millio...
Financial Highlights
Revenue: $390.351 million; YoY decline -10.95%; QoQ decline -5.14%.
Gross Profit: $84.65 million; Gross Margin: 21.69% (0.2169).
Operating Income: -$121.08 million; Operating Margin: -31.02%.
EBITDA: -$111.81 million; EBITDA Margin: -28.64% (approximate, based on EBITDA / revenue).
Net Income: -$134.59 million; Net Margin: -34.48%.
EPS: -$1.49; Weighted Avg Shares: 90.25 million (approximate from data: 90,247,000).
Cash Flow: Net cash from operating activities $4.65 million; Capex $6.92 million; Free Cash Flow -$2.28 million.
Cash and Equivalents: $44.43 million at period end; Net Debt: $730.53 million; Total Debt: $774.96 million.
Balance Sheet: Total Assets $1.844 billion; Total Liabilities $1.147 billion; Shareholdersβ Equity $696.71 million.
Liquidity: Current ratio 1.81x; Quick ratio 0.995x; Cash ratio 0.146x.
Efficiency/Turnover: Receivables Turnover 2.27x; Inventory Turnover 1.23x; Asset Turnover 0.212x; DSO 39.73 days; DIO 73.29 days; DPO 61.84 days; CCC 51.18 days.
Income Statement
| Metric |
Value |
YoY Change |
QoQ Change |
| Revenue |
390.35M |
-10.95% |
-5.14% |
| Gross Profit |
84.65M |
-12.43% |
-9.42% |
| Operating Income |
-121.08M |
-333.96% |
-31.75% |
| Net Income |
-134.59M |
-179.26% |
-29.44% |
| EPS |
-1.49 |
-175.93% |
-29.57% |
Key Financial Ratios
operatingProfitMargin
-31%
operatingCashFlowPerShare
$0.05
freeCashFlowPerShare
$-0.03
Management Commentary
Note: The dataset provided includes no earnings call transcript. As a result, thematic highlights and management quotes could not be extracted from the transcript. If you supply the QQ3 2025 earnings call transcript, I will extract management themes (strategy, operations, market conditions) and provide structured quotes with attribution.
Transcript not provided in the data.
β Management
Transcript not provided in the data.
β Management
Forward Guidance
No formal forward-looking guidance was included in the dataset for QQ3 2025. In this context, the outlook hinges on several plausible drivers: (1) Margin normalization through ongoing cost containment, SG&A optimization, and potential product mix improvement toward higher-margin SKUs; (2) Price realization and mix-shift to prioritise higher-margin organic/natural offerings, potentially aided by premiumization and branding initiatives; (3) Working capital optimization to improve free cash flow generation; (4) Debt reduction or refinancing to reduce financing costs and improve leverage metrics. Industry tailwinds for organic/natural categories could support demand, but ongoing input cost volatility and currency effects across ~80 countries remain material risks. Investors should monitor management commentary (if provided) on cost-savings trajectory, price realization, channel strategy (e-commerce vs. traditional retail), and any capital allocation decisions (debt reduction vs. share repurchases).